Empadot L 25/5 Tablet (10 Tab)

Empadot L 25/5 Tablet Overview:

Empadot L 25/5 Tablet is an oral antidiabetic medicine, used to manage blood sugar levels in adults with type 2 diabetes mellitus.

It combines two active ingredients, Empagliflozin and Linagliptin, offering a dual-action approach to control blood sugar when dietary changes, physical activity, and single medicines are not enough to maintain adequate blood glucose levels.

Type 2 diabetes occurs when the body cannot produce enough insulin or use it effectively, leading to high blood glucose levels. Uncontrolled diabetes can increase the risk of heart disease, kidney problems, nerve damage, vision loss, and slow wound healing.

Empadot L 25/5 works by helping the body remove excess glucose through urine and improving insulin function.

In addition to managing blood sugar, Empadot L 25/5 Tablet also reduces the risks of diabetes-related complications.

Always follow your doctor’s instructions, maintain a healthy lifestyle, and combine the medication with a proper diet and exercise for optimal results.

It is important to note that Empadot L 25/5 Tablet is not for treating Type 1 diabetes or diabetic ketoacidosis.

Composition:

Each film coated Empadot L 25/5 Tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, and Excipients q.s.

Colours: Red Oxide of Iron & Titanium Dioxide.

Uses & Benefits Of Empadot L 25/5 Tablet:

Empadot L 25/5 Table is specifically indicated for the treatment of Type 2 diabetes mellitus or non-insulin-dependent diabetes mellitus (NIDDM).

How Does Empadot L 25/5 Tablet Work:

Empadot L 25/5 Tablet contains Empagliflozin, a potent (SGLT2) inhibitor and Linagliptin (DPP-4) inhibitor, which work together through two distinct mechanisms to manage blood sugar level.

Empagliflozin works in the kidneys by blocking the reabsorption of glucose back into the bloodstream and removing excess glucose from the body through urine, thereby lowering blood sugar levels.

At the same time, Linagliptin increases insulin release after meals and reduces the amount of glucose produced by the liver.

Dosage Of Empadot L 25/5 Tablet:

• Usage Direction

Take Empadot L 25/5 Tablet strictly according to your doctor’s instructions, following the prescribed dose and timing. Empadot L 25/5 Tablet should be swallowed whole and not to be chewed, or crushed, preferably at the same time each day. Do not stop or alter the dose of Empadot L 25/5 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. If you are unsure about the administration procedures of Empadot L 25/5, consult with your doctor or pharmacist.

• Missed Dose

If you forget to take a dose of Empadot L 25/5 Tablet and your next dose is scheduled for more than 12 hours later, take it as soon as you recall. However, if your next dose is due within 12 hours, skip the missed dose and stick to your usual dosing routine. Avoid taking two doses if you have missed one, as it might increase the risk of side effects.

• Overdose

If you accidentally take Empadot L 25/5 Tablet more than your prescribed dose, seek immediate medical advice or contact a poison control center, even if there are no visible symptoms. Because overdose may lead to serious side effects.

Contraindications of Empadot L 25/5 Tablet:

Do not take Empadot L 25/5 Tablet if you are allergic to Empagliflozin, Linagliptin, or any of its ingredients. Signs of an allergic reaction may include skin rash, itching, hives, breathing difficulty, or swelling of the face, lips, tongue, or throat.

This medicine is not recommended for people with type 1 diabetes mellitus, diabetic ketoacidosis, or severe kidney disease, including patients with end-stage renal disease or those undergoing dialysis. Empadot L 25/5 Tablet should also not be used in children and adolescents below 18 years of age.

Precautions & Warnings Of Empadot L 25/5 Tablet:

Before taking Empadot L 25/5 Tablet, inform your doctor if you are 75 years or older or have a history of pancreatitis, liver disease, kidney problems, heart failure, low blood pressure, high LDL cholesterol, allergic reactions, or frequent urinary or genital infections. It should be used with caution in patients with type 1 diabetes, risk of hypoglycemia (especially when used with insulin), or diabetic ketoacidosis (DKA). Symptoms of DKA may include nausea, vomiting, abdominal pain, excessive thirst, breathing difficulty, confusion, unusual tiredness, or sleepiness.

If you have fever, infections, diarrhea, poor food or fluid intake, consult your doctor, as these conditions may cause dehydration. Adequate hydration and kidney function tests are important, as the medicine’s effectiveness depends on kidney health.

Side Effects of Empadot L 25/5 Tablet:

Like some other medicines, Empadot L 25/5 Tablet may cause side effects, though not everyone experiences them. The most common side effect of Empadot L 25/5 Tablet is a urinary tract infection (UTI), which may cause a burning sensation, pain, or difficulty while urinating. Other common side effects include constipation, abdominal pain, cough, skin rash, nasal or throat swelling (nasopharyngitis), weight loss, and fungal yeast infections of the genital area.

Some serious side effects may also occur and need immediate medical attention. These include diabetic ketoacidosis, pancreatitis, low blood sugar (hypoglycemia), and severe allergic skin reactions.

If you notice any unusual or worsening symptoms while taking Empadot L 25/5 Tablet, contact your doctor promptly for proper evaluation and treatment.

Safety Related Concerns of Empadot L 25/5 Tablet:

• Pregnancy

If you are pregnant or planning to become pregnant, consult your doctor before taking Empadot L 25/5 Tablet. Your doctor may switch you to a safer diabetes treatment, such as insulin, to maintain proper blood sugar control.

Careful and regular blood glucose monitoring during pregnancy is essential to reduce the risk of complications and support healthy fetal development. Always follow your doctor’s advice and do not start or stop any diabetes medication without medical guidance.

• Breastfeeding

It is better to avoid the use of the Empadot L 25/5 Tablet while breastfeeding, since it is unknown whether the active ingredients of this medicine could pass into the breast milk and affect the breastfed child. Therefore, consulting with your doctor before taking Empadot L 25/5 Tablet is crucial.

• Alcohol

Avoid drinking alcohol while taking Empadot L 25/5 Tablet, as it may cause either low or high blood sugar levels or ketoacidosis. Before taking the medicine, inform your doctor if you consume alcohol.

If you choose to drink alcohol, do so in moderation, never on an empty stomach, and monitor your blood sugar more frequently.

• Food Interactions

The interaction between specific food items and the Empadot L 25/5 Tablet is not documented, so it can be taken with or without food. However, maintaining a healthy diet is essential to regulate blood glucose levels, which can be achieved by avoiding sugary items and limiting carbohydrates, as these are primarily responsible for glucose spikes. There are no limitations regarding the tablet itself.

• Drug Interactions

Empadot L 25/5 Tablet may interact with certain medicines. Inform your doctor if you are taking diuretics (water pills), as they can increase the risk of dehydration. Using it with insulin or sulfonylureas may raise the chance of low blood sugar, so dose adjustments may be needed. Medicines such as rifampicin, carbamazepine, phenobarbital, and phenytoin may reduce the effectiveness of this tablet. The tablet might also interact with drugs that treat mood disorders like lithium and reduce its level in the blood.

Always inform your healthcare provider and pharmacist about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, minerals, and herbal supplements, to avoid potential interactions.

• Using Machinery & Driving

Using Empadot L 25/5 Tablet may affect your ability to drive or operate machinery, especially when taken with other antidiabetic medicines such as insulin or sulphonylureas. These combinations can cause low blood sugar (hypoglycemia), which may lead to symptoms like blurred vision, dizziness, shaking, sweating, or confusion.

It is important to recognize early signs of low blood sugar and avoid driving or risky activities if you feel unwell or dizzy. Always carry a quick source of glucose, such as fruit juice or sugar tablets, and monitor your blood sugar regularly during treatment.

Storage of Empadot L 25/5 Tablet:

Store in a cool, dry, and dark place. Keep out of reach of children.

Do not use the medicine past its expiration date printed on the packaging. Dispose of expired or unused medication properly according to local guidelines or by returning it to a pharmacy take-back program.

Additional Notes:

• Regular monitoring of blood sugar levels at home, or as directed by your doctor.
• Maintain all scheduled appointments for blood tests and check-ups to monitor kidney function, liver function, and other parameters.
• Drink plenty of water to support kidney function and prevent dehydration.
• Maintain a healthy lifestyle, including a balanced diet, regular physical activity, weight management, and stress reduction.
• Carry quick sugar sources in case of low blood sugar.
• Foot amputation is one of the complication of diabetes, so regular monitoring of foot and foot care should be done on a regular basis.
• Do not share your medicine with other persons, even if they also have similar symptoms.

Related Blood Glucose Monitors:

To manage diabetes at home, discover our simple, reliable home-use Blood Glucose Monitoring systems with Test Strips. Check Out

Frequently Asked Questions (FAQs):

Q1. What is Empadot L 25/5 Tablet used for?

A: Empadot L 25/5 Tablet is mainly used in type 2 diabetes mellitus, where it helps to manage the blood glucose level in adult patients, especially when a single drug is not enough. Additionally, it also reduces the risk of heart disease associated with type 2 diabetes.

Q2. Is Empadot L 25/5 Tablet used for Type 2 diabetes only?

A: Yes, Empadot L 25/5 Tablet is specifically used for type 2 diabetes and should not be used for type 1 diabetes. Because using in type 1 diabetes may lead to a life-threatening condition called Diabetic Ketoacidosis.

Q3. Does Empadot L 25/5 Tablet help with weight loss?

A: Empadot L 25/5 Tablet might result in slight weight loss for many patients due to the loss of calories through glucose in their urine. However, if you notice significant weight loss, it is essential to consult your doctor right away.

Q4. Can Empadot L 25/5 Tablet be taken with other diabetes medicines?

A: Certainly, Empadot L 25/5 Tablet can be combined with other treatments like Metformin, Insulin, or Sulfonylureas. However, these medications might interfere with each other, and your healthcare provider may need to adjust the dosage accordingly. Therefore, it is advisable to take it only under close medical supervision.

Q5. Is Empadot L safe for patients with kidney problems?

A: Empadot L 25/5 Tablet can be used safely in patients with mild to moderate kidney impairment under medical supervision. However, it is not recommended for people with severe kidney disease or those undergoing dialysis. Your doctor may regularly perform kidney function tests during treatment to ensure the medicine is working effectively and remains safe for you.

Q6. Who should not take Empadot L 25/5 Tablet?

A: Empadot L 25/5 Tablet should be avoided if you are under 18 years of age, pregnant, or breastfeeding. Do not take this medicine if you have severe kidney disease, are on dialysis, or have type 1 diabetes. It is also not suitable for patients with a history of pancreatitis, liver problems, or known allergy to any of its ingredients.

References:

1. GLYXAMBI® (empagliflozin and linagliptin) tablets, for oral use. HIGHLIGHTS OF PRESCRIBING INFORMATION. Last Revised: August 2017. Accessed on: 30th December 2025. Click Here
2. Package leaflet: Information for the patient. Glyxambi®10 mg/5 mg film-coated tablets Last Revised: March 2025. Accessed on: 30th December 2025. Click Here
3. Linjardy (Linagliptin + Empagliflozin Tablet). Accessed on: 30th December 2025. Click Here